• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BXN
Click for more information
14.3% 0.6¢

BIOXYNE LIMITED

Market Cap $12.28M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Household & Personal Products

Bioxyne Limited is an Australia-based health and wellness products company. Its activity... Bioxyne Limited is an Australia-based health and wellness products company. Its activity is the development, manufacture and distribution of nutritional health and wellness supplements through indirect wholesale and direct sales channels in the health and wellness sector. It is engaged in the consumer dietary supplements and functional foods markets through its probiotic, Lactobacillus fermentum VRI-003 (PCC). The Company has developed a range of functional food and beauty products containing ingredients sourced primarily from New Zealand, through its direct sales business trading as Bioxyne International. It has an interest in Breathe Life Sciences (BLS). It has operations across Australia, the United Kingdom, Japan, Europe and Southeast Asia with a health and wellness product portfolio, including health supplements, skincare, probiotics, cannabis-derived raw materials, starting materials, active pharmaceutical ingredients, cannabinoid-based therapies and telemedicine technology.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BXN
Bioxyne going places > big orders 		30/04/24 7 3.8K
30/04/24 Last post  BagsOBucks Comments Created with Sketch.  7  Views Created with Sketch.  3.8K 
BXN
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		30/04/24 0 73
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  73 
BXN
Ann: Cleansing Notice 		22/04/24 0 86
TRENDING NEWS

Access the latest Thematics Insights Report: What it takes to get a new drug to market in Australia

Read More   right-arrow Created with Sketch.
NEWS
08 May 2024
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  86 
BXN
Ann: Application for quotation of securities - BXN 		22/04/24 0 128
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  128 
BXN
News: BXN Bioxyne Says Received Firm Commitments To Raise A$1.45 Million At A$0.01 Per Share 		18/04/24 0 134
18/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  134 
BXN
Ann: Proposed issue of securities - BXN 		18/04/24 0 101
18/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  101 
BXN
Ann: Bioxyne Receives Firm Commitments to Raise $1.45 Million 		18/04/24 0 179
18/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  179 
BXN
DONT FALL IN THE TRAP 		28/03/24 0 289
28/03/24 Last post  pakkham Comments Created with Sketch.  0  Views Created with Sketch.  289 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:02
 
Cleansing Notice
22 Apr 08:33
 
Application for quotation of securities - BXN
22 Apr 08:32
 
Proposed issue of securities - BXN
18 Apr 09:40
 
Bioxyne Receives Firm Commitments to Raise $1.45 Million
18 Apr 08:54
 
Bioxyne to Host Webinar on 28 March 2024
25 Mar 14:23
 
View More arrow Created with Sketch.

Featured News

ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
(20min delay)
Last
0.6¢ 		Change
-0.001(14.3%) 		Mkt cap ! $12.28M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $16.93K 2.822M

Buyers (Bids)

No. Vol. Price($)
3 2184669 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1914701 5
View Market Depth
Last trade - 15.13pm 08/05/2024 (20 minute delay) ?
Last
0.6¢ 		  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.6¢ 0.6¢ 0.6¢ 486600
Last updated 10.13am 08/05/2024 ?
BXN (ASX) Chart

Top Stories

Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne

Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production Alara Resources has set itself up nicely in Oman to capitalise on an expected 75% surge in copper prices over the next two years.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.

Featured News

AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.